Related Experiment Video
Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Alzheimer's Imaging Consortium
Michelle R Caunca1, Amber L Bahorik2, Xiaqing Jiang2
1Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Background:
Emerging data illustrates important differences in dementia-related pathology by race/ethnicity and gender, similar to patterns in cardiovascular risk. We hypothesized that neuroimaging markers of dementia would differ by race/ethnicity and gender and that cardiovascular risk would partially mediate these associations.
Methods:
Using the Health and Brain Study-Health Disparities data (HABS-HD), we estimated the impact of racial/ethnic and gender differences on neuroimaging markers of cerebrovascular disease (white matter hyperintensity volume [WMHV]) and neurodegeneration (AD ROI cortical thickness [in mm], global amyloid and medial temporal tau deposition [SUVR]) in dementia-free participants. Linear and multinomial regression was used, adjusting for age, race/ethnicity, gender, race/ethnicity*gender, years of education, income, insurance status, marital status, and intracranial volume (for WMHV). Stratified analyses were performed if race/ethnicity*gender term p <0.10. Framingham Risk Score (FRS) was added to examine mediation by cardiovascular risk.
Results:
Among 3289 participants with either MRI or PET data available at their baseline visit (63% women, 26% Black, 37% Hispanic, and 36% non-Hispanic white), 34% and 13% had an intermediate and high FRS, respectively. Women of color had the highest odds of an intermediate FRS (OR [95% CI], Black: 2.05 [1.53, 2.76], Hispanic: 2.29 [1.68, 3.12]), and Hispanic men had the highest odds of a high FRS (2.78 [1.72, 4.51]), compared to non-Hispanic whites. Black participants had lower amyloid-beta SUVR compared to non-Hispanic whites (ß [95% CI]: -0.04 [-0.07, -0.02]). AD ROI cortical thickness did not differ by race/ethnicity and gender. Women of color had greater medial temporal tau SUVR (ß [95% CI], Black: 0.06 [0.04, 0.09], Hispanic: 0.08 [0.05, 0.12]). Associations with amyloid or tau SUVR were stable with adjustment of FRS. Black participants had greater WMHV (ß [95% CI], men: 0.38 [0.21, 0.55], women: 0.17 [0.06, 0.28]), while Hispanic participants had lower WMHV (though not significantly). Adjustment for FRS partially mediated associations for Black women (ß [95% CI], 0.15 [0.04, 0.27]).
Conclusions:
Cardiovascular risk and neuroimaging markers of dementia vary jointly by race/ethnicity. Women of color may have a greater likelihood of tau deposition and benefit more from reduction of cardiovascular risk to reduce small vessel disease burden.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...